These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 21456944)
1. Tumor thickness predicts long-term complete response of facial basal cell carcinomas in Asian skin types iv/v treated with methyl aminolaevulinate photodynamic therapy. Li Q; Gao T; Jiao B; Hu X; Luan Q; Li K; Ma C; Li C; Wang S Photomed Laser Surg; 2011 Jul; 29(7):501-7. PubMed ID: 21456944 [TBL] [Abstract][Full Text] [Related]
7. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up. Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial. Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655 [TBL] [Abstract][Full Text] [Related]
12. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy. Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644 [TBL] [Abstract][Full Text] [Related]
13. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Rhodes LE; de Rie MA; Leifsdottir R; Yu RC; Bachmann I; Goulden V; Wong GA; Richard MA; Anstey A; Wolf P Arch Dermatol; 2007 Sep; 143(9):1131-6. PubMed ID: 17875873 [TBL] [Abstract][Full Text] [Related]
15. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H; J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836 [TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp. Zane C; Facchinetti E; Rossi MT; Specchia C; Calzavara-Pinton PG Br J Dermatol; 2014 May; 170(5):1143-50. PubMed ID: 24506666 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy in the management of basal cell carcinoma: Retrospective evaluation of outcome. Jerjes W; Hamdoon Z; Hopper C Photodiagnosis Photodyn Ther; 2017 Sep; 19():22-27. PubMed ID: 28442314 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. Fantini F; Greco A; Del Giovane C; Cesinaro AM; Venturini M; Zane C; Surrenti T; Peris K; Calzavara-Pinton PG J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):896-901. PubMed ID: 21054566 [TBL] [Abstract][Full Text] [Related]
19. Experience and BCC subtypes as determinants of MAL-PDT response: preliminary results of a national Brazilian project. Ramirez DP; Kurachi C; Inada NM; Moriyama LT; Salvio AG; Vollet Filho JD; Pires L; Buzzá HH; de Andrade CT; Greco C; Bagnato VS Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):22-6. PubMed ID: 24412582 [TBL] [Abstract][Full Text] [Related]
20. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Basset-Seguin N; Ibbotson SH; Emtestam L; Tarstedt M; Morton C; Maroti M; Calzavara-Pinton P; Varma S; Roelandts R; Wolf P Eur J Dermatol; 2008; 18(5):547-53. PubMed ID: 18693158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]